PL BioScience GmbH | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
PL BioScience GmbH

BRIEF

published on 05/08/2025 at 14:05, 6 months 27 days ago

PL BioScience Unveils World's First Artificial Human Platelet Lysate

Regenerative Medicine Biopharmaceuticals Cell Culture PL BioScience Artificial HPL
PRESS RELEASE

published on 05/08/2025 at 14:00, 6 months 27 days ago

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
PL BioScience GmbH introduces first artificial Human Platelet Lysate (HPL) worldwide, revolutionizing cell culture technology for biopharmaceutical applications

Biopharmaceutical Human Platelet Lysate PL BioScience Artificial Cell Culture Technology
BRIEF

published on 04/30/2025 at 12:05, 7 months 4 days ago

PL BioScience Unveils Unique Gamma-irradiated Human Platelet Lysate

Regenerative Medicine Cell Therapy Human Platelet Lysate Gamma-Irradiation Xeno-Free Supplement
PRESS RELEASE

published on 04/30/2025 at 12:00, 7 months 4 days ago

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate
PL BioScience launches ELAREM™ Ultimate-FD PLUS, the only gamma-irradiated, GMP-grade Human Platelet Lysate in Europe. The product offers a safer, sustainable, virus-inactivated, and animal-free alternative for cell manufacturing applications

GMP-grade Human Platelet Lysate PL BioScience ELAREM Ultimate-FD PLUS Gamma-irradiated

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 43 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 48 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 18 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 13 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 18 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 48 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 27 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 53 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 3 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 8 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 18 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 33 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 34 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 17 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE